Lymphosep - Lymphocyte Separation Medium is a sterile, iso-osmotic, low viscosity solution for density centrifugation yielding a clear separation of lymphocytes from heparinized or defibrinated human blood. Lymphocytes are isolated by layering diluted, heparinized blood over a solution of sodium metrizoate that contains a polysaccharide. This polysaccharide aggregates the erythrocytes so that they can be sedimented by low centrifugation. The less dense lymphocytes remain as a clearly defined band at the plasma Lymphosep interface.
- Maximum yield of mononuclear cells
- Easy one-step centrifugation
- >96% cell viability of lymphocytes
- Low endotoxins
- Autoclave sterilization
Check out our latest article in Genetic Engineering & Biotechnology News about High-Performance Density Gradient Media for Purification of Leukocytes from Blood.
LSM is formulated for isolation of mononuclear cells from defibrinated or heparinized whole human blood. One-step centrifugation permits separation of mononuclear lymphocytes from erythrocytes, polynuclear lymphocytes and most platelets.
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
In vitro isolation of lymphocytes from diluted whole blood.
|Application Notes||LSM is formulated for isolation of mononuclear cells from defibrinated or heparinized whole human blood. One-step centrifugation permits separation of mononuclear lymphocytes from erythrocytes, polynuclear lymphocytes and most platelets.|
|Base Catalog Number||1692249,1692254|
|Formulation Details||Liquid - Lymphosep is supplied as a ready made sterile aqueous solution of sodium metrizoate (9.6% w/v) and Ficoll® (5.6% w/v).|
|Media Type||Lymphocyte Separation Media|
|pH||6.0 - 9.0|
Certificates of Analysis
Material Safety Data Sheet
Peripheral Blood Case Study
Exposures to the environmental toxicants pentachlorophenol (PCP) and dichlorodiphenyltrichloroethane (DDT) modify secretion of interleukin 1-beta (IL-β) from human immune cells.